Contact
Please use this form to send email to PR contact of this press release:
OCT Сlinical, contracted to run CanSinoBIO’s Covid-19 vaccine study in Russia, reports on progress
TO:
Amaliya Ilyasova
OCT Clinical
+7 981 709-20-60